|
|
|
|
Study results from D.J. Cuthbertson and colleagues in the area of pituitary cancer published
- (NewsRx.com) -- 'Lymphocytic Hypophysitis (LH) is a rare and previously under-recognised disorder, most commonly affecting young females in the post-partum period (see also Pituitary Cancer).It presents clinically with symptoms and...
|
|
|
Outbreak of exogenous Cushings syndrome due to unlicensed medications
Azizi F et al.- Surreptitious use of steroids resulting in Cushing's syndrome may be more common in opium addicts; a high degree of suspicion is needed to uncover this disorder. Outbreak of exogenous Cushings syndrome due to...
|
|
|
Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and amb
Nunes ML et al.- The authors data validate the outpatient bed sampling strategy for NSC with no need for specific outpatient threshold. NSC may be helpful to detect mild recurrence of Cushing's disease after surgery but is of...
|
|
|
Help Norfolk's teenage cancer victims
Sonia Hyvonen and Barbara Cushing, local organisers, with cancer sufferer Lucy Smith, Deb Jordan, local organiser, and Helen Bearfield-Smith, regional appeals manager, at the launch of the teenage cancer appeal LORNA MARSH 14 November...
|
|
|
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist caber
Pivonello R et al.- The results of this study demonstrated that cabergoline treatment is effective in controlling cortisol secretion for at least 12 years in more than one third of a limited population of patients with CD. The medical...
|
|
|
Corcept Therapeutics Announces Third Quarter 2008 Results
Corcept Therapeutics Incorporated (NASDAQ: CORT) today reported financial results for the third quarter ended September 30, 2008.For the third quarter of 2008, Corcept reported a net loss of $5.6 million, or $0.11 per share, compared to a...
|
|
|
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business
PARSIPPANY, N.J., Nov.12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these...
|
|
|
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business
PARSIPPANY, N.J., Nov.12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these...
|
|
|
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business
PARSIPPANY, N.J., Nov.12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these...
|
|
|
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business
PARSIPPANY, N.J., Nov.12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these...
|
|
|
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business
PARSIPPANY, N.J., Nov.12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these...
|
|
|
Research Identifies Predictors for Successful IVF
Ferring Pharmaceuticals Presents Infertility Study Results at American Society for Reproductive Medicine Annual Meeting SAN FRANCISCO, Nov.10 /PRNewswire/ -- Ferring Pharmaceuticals presented the results of a number of studies in assisted...
|
|
|
Plymouth South High School honor roll
The following students are on the for the first quarter: SENIORS HIGH HONORS Tiian Amick, Erik Anderson, Michael Anzuoni, Jordan Auriemma, Adam Azar, Samantha Ballert, Daniel Barry II, Hannah Blangiardo, Rae Brightman, Stephanie Burr, Marie...
|
|
|
Consider ACTH stimulation test when you suspect canine hyperadrenocorticism
Figure 1: Abbreviated steroid production pathway adapted from (2) Ristic shows those steroid hormones evaluated by the adrenal panel profile.Note: Trilostane inhibits those pathways involving 3B hydroxysteroid dehydrogenase. Increased...
|
|
|
Redefining veterinary medicine
Table 1 Keeping pace with the population PORTLAND, ORE.The alarms are sounding again to increase the number of veterinarians in the United States. Demand is simply outpacing supply, according to some academic and practice leaders at the...
|
|
|
K-State Veterinarian Discusses Treating Dogs With Cushing's Disease
MANHATTAN, Kan., Nov.4 /PRNewswire-USNewswire/ -- A new medication is available to treat dogs with Cushing's disease, but pet owners should be prepared for the cost of managing the disease, according to a veterinarian at Kansas...
|
|
|
KVeterinarian Discusses New Drug For Dogs With Cushing's Disease
Newswise A new medication is available to treat dogs with Cushing's disease, but pet owners should be prepared for the cost of managing the disease, according to a veterinarian at 's College of Veterinary Medicine.Kenneth Harkin,...
|
|
|
K-State Veterinarian Discusses Treating Dogs With Cushing's Disease
_ K-State Veterinarian Discusses Treating Dogs With Cushing's Disease.
|
|
|
K-State Veterinarian Discusses Treating Dogs With Cushing's Disease
MANHATTAN, Kan., Nov.4 /PRNewswire-USNewswire/ -- A new medication is available to treat dogs with Cushing's disease, but pet owners should be prepared for the cost of managing the disease, according to a veterinarian at Kansas...
|
|
|
KVeterinarian Discusses New Drug For Dogs With Cushing's Disease
Kenneth Harkin, associate professor of clinical sciences, said a new drug called Trilostane is undergoing approval by the Food and Drug Administration, but veterinarians may obtain the medication if they decide it is the necessary choice to...
|
|
|
Study results from National Institute of Child Health and Human Development broaden understanding of hyperplas
- (NewsRx.com) -- New investigation results, 'A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex,' are detailed in a...
|
|
|
Study results from National Institute of Child Health and Human Development broaden understanding of hyperplas
- (NewsRx.com) -- New investigation results, 'A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex,' are detailed in a...
|
|
|
Inhibition of olfactory neurosensory function to treat eating disorders and obesity
Title: United States Patent: 7,435,407 Inventors: Adams; Christopher P.(Somerville, MA), Flynn; James (Lexington, MA) Assignee: Compellis Pharmaceuticals (Somerville, MA) Appl. No.: 11/528,978 Filed: September 27, 2006 The use of...
|
|
|
Ferring Celebrates Winner of 2008 My Little Miracle Essay Contest During National Infertility Awareness Week
Contest Brings Hope and Awareness to Millions of Couples Struggling With Infertility PARSIPPANY, N.J., Oct.23 /PRNewswire/ -- Ferring Pharmaceuticals is honoring 12 lucky families who won the national 2008 My Little Miracle Essay Contest...
|
